Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

CCL2 is a KIT D816V–dependent modulator of the bone marrow microenvironment in systemic mastocytosis

Georg Greiner, Nadine Witzeneder, Angelika Berger, Klaus Schmetterer, Gregor Eisenwort, Ana-Iris Schiefer, Simone Roos, Theresia Popow-Kraupp, Leonhard Müllauer, Johannes Zuber, Veronika Sexl, Lukas Kenner, Wolfgang R. Sperr, Peter Valent, Matthias Mayerhofer, Gregor Hoermann

Blood (2017) 129 (3): 371–382.

https://doi.org/10.1182/blood-2016-09-739003

Published: 2017

Includes: Supplemental data

Journal Articles

In Contemporary Patients with Polycythemia Vera, Rates of Thrombosis and Risk Factors Delineate a New Clinical Epidemiology

Tiziano Barbui, MD, Alessandra Carobbio, MSc, Elisa Rumi, MD, Guido Finazzi, MD, Heinz Gisslinger, MD, Francesco Rodeghiero, Maria Luigia Randi, MD, Alessandro Rambaldi, Bettina Gisslinger, MSc, Lisa Pieri, MD PhD, Irene Bertozzi, Ilaria Carola Casetti, MD, Leonhard Müllauer, MD, Animesh Pardanani, MBBS, PhD, Jürgen Thiele, MD PhD, Francesco Passamonti, MD, Alessandro M. Vannucchi, MD, Ayalew Tefferi, MD

Blood (2014) 124 (21): 1822.

https://doi.org/10.1182/blood.V124.21.1822.1822

Published: 2014

Journal Articles

Bromodomain-Containing Protein 4 (BRD4): A Novel Marker and Drug Target Expressed In Neoplastic Cells In Advanced Mast Cell Neoplasms

Ghaith Wedeh, Emir Hadzijusufovic, DVM, Sabine Cerny-Reiterer, D.V.M, Harald Herrmann, M.D., Katharina Blatt, MSc, Ph.D., Gregor Eisenwort, M.D., Ph.D, Gregor Hoermann, M.D., Ph.D., Wolfgang R Sperr, M.D., Leonhard Müllauer, M.D., Christopher R. Vakoc, M.D., Ph.D., James E Bradner, MD, Hans-Peter Horny, MD, Michael Willmann, D.V.M., Johannes Zuber, MD, Michel Arock, PharmD, Ph.D, Peter Valent

Blood (2013) 122 (21): 3747.

https://doi.org/10.1182/blood.V122.21.3747.3747

Published: 2013

Journal Articles

B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ

Elisabeth Salzer, Elisangela Santos-Valente, Stefanie Klaver, Sol A. Ban, Wolfgang Emminger, Nina Kathrin Prengemann, Wojciech Garncarz, Leonhard Müllauer, Renate Kain, Heidrun Boztug, Andreas Heitger, Klaus Arbeiter, Franz Eitelberger, Markus G. Seidel, Wolfgang Holter, Arnold Pollak, Winfried F. Pickl, Elisabeth Förster-Waldl, Kaan Boztug

Blood (2013) 121 (16): 3112–3116.

https://doi.org/10.1182/blood-2012-10-460741

Published: 2013

Includes: Supplemental data

Journal Articles

Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial

Andrés J. M. Ferreri, Silvia Govi, Markus Raderer, Antonino Mulè, Alessandro Andriani, Daniele Caracciolo, Liliana Devizzi, Fiorella Ilariucci, Stefano Luminari, Edi Viale, Leonhard Müllauer, Stefania Dell'Oro, Paolo Giorgio Arcidiacono, Maurilio Ponzoni, Caterina Patti

Blood (2012) 120 (18): 3858–3860.

https://doi.org/10.1182/blood-2012-06-438424

Published: 2012

Journal Articles

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

Felix Sahm, David Capper, Matthias Preusser, Jochen Meyer, Albrecht Stenzinger, Felix Lasitschka, Anna-Sophie Berghoff, Antje Habel, Marion Schneider, Andreas Kulozik, Ioannis Anagnostopoulos, Leonhard Müllauer, Gunhild Mechtersheimer, Andreas von Deimling

Blood (2012) 120 (12): e28–e34.

https://doi.org/10.1182/blood-2012-06-429597

Published: 2012

Includes: Supplemental data

Journal Articles

A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

Blood (2012) 120 (6): 1197–1201.

https://doi.org/10.1182/blood-2012-01-403279

Published: 2012

Includes: Supplemental data

Journal Articles

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

Blood (2012) 119 (10): 2239–2241.

https://doi.org/10.1182/blood-2011-11-393819

Published: 2012

Journal Articles

A PROGNOSTIC MODEL to PREDICT SURVIVAL In WHO-DEFINED ESSENTIAL THROMBOCYTHEMIA: A STUDY by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

Blood (2011) 118 (21): 1746.

https://doi.org/10.1182/blood.V118.21.1746.1746

Published: 2011

Journal Articles

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

Jürgen Thiele, Hans Michael Kvasnicka, Leonhard Müllauer, Veronika Buxhofer-Ausch, Bettina Gisslinger, Heinz Gisslinger

Blood (2011) 117 (21): 5710–5718.

https://doi.org/10.1182/blood-2010-07-293761

Published: 2011

Journal Articles

Plasmacytoid dendritic cells express TRAIL and induce CD4 + T-cell apoptosis in HIV-1 viremic patients

Georg Stary, Irene Klein, Sabine Kohlhofer, Frieder Koszik, Thomas Scherzer, Leonhard Müllauer, Heribert Quendler, Norbert Kohrgruber, Georg Stingl

Blood (2009) 114 (18): 3854–3863.

https://doi.org/10.1182/blood-2009-04-217927

Published: 2009

Includes: Supplemental data

NARROW

CCL2 is a KIT D816V–dependent modulator of the bone marrow microenvironment in systemic mastocytosis

In Contemporary Patients with Polycythemia Vera, Rates of Thrombosis and Risk Factors Delineate a New Clinical Epidemiology

Bromodomain-Containing Protein 4 (BRD4): A Novel Marker and Drug Target Expressed In Neoplastic Cells In Advanced Mast Cell Neoplasms

B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ

Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

A PROGNOSTIC MODEL to PREDICT SURVIVAL In WHO-DEFINED ESSENTIAL THROMBOCYTHEMIA: A STUDY by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

Plasmacytoid dendritic cells express TRAIL and induce CD4 + T-cell apoptosis in HIV-1 viremic patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only